alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 13,276–13,300 of 27,380 studies, newest first · page 532 of 1096.

January 2019 25

  1. 2019 year only

    Palliative medicine and end-of-life care

    ✓ Peer-reviewed End-of-life care Handbook of clinical neurology

    Key finding: Patients and families affected by a neurodegenerative illness have significant palliative care needs beginning at the time of diagnosis and extending through end-of-life care and bereavement.

    Full summary, score breakdown and related studies → Original source

  2. 2019-01 month only

    Risk of caregiver burden in patients with three types of dementia

    ✓ Peer-reviewed Caregiving International psychogeriatrics

    Key finding: (2017) investigated caregiver burden of patients with frontotemporal lobar degeneration (FTD) and dementia with Lewy bodies (DLB), which was compared with caregivers of patients with Alzheimer's disease. +1 more finding

    Full summary, score breakdown and related studies → Original source

  3. 2019 year only

    Noradrenergic Regulation of Hippocampus-Dependent Memory

    ✓ Peer-reviewed Disease mechanisms Central nervous system agents in medicinal chemistry

    Key finding: Changes in synaptic strength are widely considered to be a cellular representation of learned information. +4 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2019 year only

    Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease

    ✓ Peer-reviewed Vascular contributions Journal of Alzheimer's disease : JAD

    Key finding: The number of microbleeds was significantly correlated with the severity of decrease in the occipital lobe (Spearman's r = 0.531, p < 0.001) and temporal lobe (r = 0.437, p < 0.001) but not in the frontal lobe (r = 0.201, p = 0.101) and parietal lobe (r = 0.178, p = 0.146). +3 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2019 year only

    Pericytes in Alzheimer's Disease: Novel Clues to Cerebral Amyloid Angiopathy Pathogenesis

    ✓ Peer-reviewed Vascular contributions Advances in experimental medicine and biology

    Key finding: Pericytes in the central nervous system attract growing attention of neurobiologists because of obvious opportunities to use them as target cells in numerous brain diseases. +4 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2019 year only

    Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease

    ✓ Peer-reviewed Vascular contributions Journal of Alzheimer's disease : JAD

    Key finding: Mitochondrial dysfunction is increasingly recognized as an important early initiator of the pathogenesis of AD and CAA. +4 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2019 year only

    Neurovascular Ageing and Age-Related Diseases

    ✓ Peer-reviewed Vascular contributions Sub-cellular biochemistry

    Key finding: Ultimately, the integrity of both the neurovascular and gliovascular units is compromised such that there is an overall synergistic effect reflecting on ageing associated cerebral perfusion and permeability. +1 more finding

    Full summary, score breakdown and related studies → Original source

  8. 2019 year only

    Blood Flow Deficits and Cerebrovascular Changes in a Dietary Model of Hyperhomocysteinemia

    ✓ Peer-reviewed Vascular contributions ASN neuro

    Key finding: Blood flow deficits and barrier permeability changes occurred alongside changes in memory and in genes associated with metabolism, endothelial nitric oxide signaling, barrier integrity, and extracellular matrix remodeling. +2 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2019-01 month only

    The intestinal microbiome and its relevance for functionality in older persons

    ✓ Peer-reviewed Disease mechanisms Current opinion in clinical nutrition and metabolic care

    Key finding: Some observational studies have instead demonstrated that, in older individuals, frailty and Alzheimer-type dementia are associated with fecal microbiota dysbiosis, that is, reduced biodiversity and overexpression of pathobionts. +1 more finding

    Full summary, score breakdown and related studies → Original source

  10. 2019 year only

    Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy

    ✓ Peer-reviewed Inflammation and the immune system Journal of Alzheimer's disease : JAD

    Key finding: IL-1β, IL-18, and caspase-1 were increased whereas Aβ phagocytosis and TREM2 were reduced in LPS+Aβ42-stimulated cells. +4 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2019 year only

    Mild Cognitive Impairment and Dementia Involving Multiple Cognitive Domains in Mexican Urbanites

    ✓ Peer-reviewed Risk factors Journal of Alzheimer's disease : JAD

    Key finding: Exposures to fine particulate matter PM2.5 and ozone O3 are associated with Alzheimer's disease (AD) risk. +1 more finding

    Full summary, score breakdown and related studies → Original source

  12. 2019 year only

    Fine Particulate Matter Exposure and Cerebrospinal Fluid Markers of Vascular Injury

    ✓ Peer-reviewed Risk factors Journal of Alzheimer's disease : JAD

    Key finding: Among cognitively normal individuals, a 5 μg/m3 increase in 7-day and 1-year average PM2.5 was associated with elevated VCAM-1 (7-day: 35.4 (9.7, 61.1) ng/ml; 1-year: 51.8 (6.5, 97.1) ng/ml). +4 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2019 year only

    Dementia Around the World and the Latin America and Mexican Scenarios

    ✓ Peer-reviewed Risk factors Journal of Alzheimer's disease : JAD

    Key finding: Dementia risk factors are significantly different among countries. +1 more finding

    Full summary, score breakdown and related studies → Original source

  14. 2019 year only

    Cognitive Reserve in Midlife is not Associated with Amyloid-β Deposition in Late-Life

    ✓ Peer-reviewed Risk factors Journal of Alzheimer's disease : JAD

    Key finding: Midlife cognition was significantly associated with late-life cognition, but not with late-life elevated SUVR; education was not associated with late-life SUVR, but was strongly associated with late-life cognition.

    Full summary, score breakdown and related studies → Original source

  15. 2019 year only

    Bilingualism and Dementia: Cognitive Reserve to Linguistic Competency

    ✓ Peer-reviewed Risk factors Journal of Alzheimer's disease : JAD

    Key finding: Despite the large number of elderly bilinguals at risk for Alzheimer's disease (AD) and dementia worldwide, significant questions remain about the relationship between speaking more than one language and later cognitive decline. +2 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2019 year only

    Cognitive reserve and dementia A scientometric review

    ✓ Peer-reviewed Risk factors Dementia & neuropsychologia

    Key finding: The results revealed that author Stern Y had the highest number of publications and citations.

    Full summary, score breakdown and related studies → Original source

  17. 2019 year only

    Therapeutic Approaches to Alzheimer's Type of Dementia: A Focus on FGF21 Mediated Neuroprotection

    ✓ Peer-reviewed Risk factors Current pharmaceutical design

    Key finding: With the identification of insulin and insulin receptors in some parts of the brain, it has become evident that certain metabolic conditions associated with insulin dysfunction like Type 2 diabetes mellitus (T2DM), dyslipidemia, obesity etc., are also known to contribute to neurodegeneration mainly Alzheimer's Disease (AD).

    Full summary, score breakdown and related studies → Original source

  18. 2019 year only

    [Presbyacusis]

    ✓ Peer-reviewed Risk factors Vestnik otorinolaringologii

    Key finding: Age-related hearing loss is the result of the biological process of aging of the tissue elements of the auditory analyzer. +1 more finding

    Full summary, score breakdown and related studies → Original source

  19. 2019 year only

    Role of Obstructive Sleep Apnea in Cognitive Impairment

    ✓ Peer-reviewed Risk factors International journal of head and neck surgery

    Key finding: Emerging science suggest that untreated and undertreated OSA increases the risk of developing cognitive impairment, including vascular dementia and neurodegenerative disorders, like Alzheimer's disease. +1 more finding

    Full summary, score breakdown and related studies → Original source

  20. 2019 year only

    [Sleep and cognitive impairment in neurodegenerative diseases]

    ✓ Peer-reviewed Risk factors Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

    Key finding: Sleep and wakefulness disorders are commonly seen in patients with Parkinson's disease, Lewy body dementia and Alzheimer's disease. +3 more findings

    Full summary, score breakdown and related studies → Original source

  21. 2019 year only

    Sleep physiology and disorders in aging and dementia

    ✓ Peer-reviewed Risk factors Handbook of clinical neurology

    Key finding: Sleep problems occur commonly in normal and pathologic aging. +4 more findings

    Full summary, score breakdown and related studies → Original source

  22. 2019 year only

    Systematic Multi-Domain Alzheimer's Risk Reduction Trial (SMARRT): Study Protocol

    ✓ Peer-reviewed Prevention trials Journal of Alzheimer's disease : JAD

    Key finding: Randomization will be stratified by clinic, race/ethnicity (non-Hispanic white versus non-white or Hispanic), and age (70-79, 80-89).

    Full summary, score breakdown and related studies → Original source

  23. 2019 year only

    A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease

    ✓ Peer-reviewed Clinical trials Journal of Alzheimer's disease : JAD

    Key finding: The safety profile was similar for 20 μg treatment and placebo patients. +4 more findings

    Full summary, score breakdown and related studies → Original source

  24. 2019 year only

    A Review for Lithium: Pharmacokinetics, Drug Design, and Toxicity

    ✓ Peer-reviewed Drug development CNS & neurological disorders drug targets

    Key finding: Recent studies have also shown that it has the potential for the treatment of many other neurodegenerative disorders, including Alzheimer's, Parkinson's and Huntington's disease, through its neurotrophic, neuroprotective, antioxidant and anti-inflammatory actions.

    Full summary, score breakdown and related studies → Original source

  25. 2019 year only

    Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning

    ✓ Peer-reviewed Treatments Current pharmaceutical design

    Key finding: The treatment approach of inhibiting peripheral AChE for myasthenia gravis had effectively proven that AChE inhibition was a reachable therapeutic target. +4 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →